Functional dyspepsia (or 'non-ulcer') is usually defined as chronic or
intermittent upper abdominal symptoms for which no organic cause can
be found. Division of functional dyspepsia into subgroups such as refl
ux-like, ulcer-like, dysmotility-like and non-specific dyspepsia has b
een proposed, but lacks a scientific basis. Gastric acid hypersecretio
n, Helicobacter pylori-associated gastritis, gastric and small intesti
nal motor disorders, psychological and neurohormonal factors all might
play a role in the pathogenesis. The heterogeneity of the underlying
abnormalities makes it unlikely that one single treatment modality wil
l ever be beneficial to all patients. In general practice, a therapeut
ic trial, with either a prokinetic or an acid secretion inhibiting dru
g, is usually carried out before diagnostic procedures are performed t
o exclude organic abnormalities. In the choice of the initial therapy,
some guidance can be derived from the prominent symptoms. In a study
in 30 H. pylori-negative patients with functional dyspepsia ranitidine
(150 mg bid) significantly reduced the severity of heartburn. The eff
ect was most pronounced in patients of the reflux-like subgroup.